| INTRODUC TI ON
Cleft lip and/or palate (CLP) are a category of craniofacial malformations characterized by the presence of spaces or gaps leading to an abnormal upper lip, alveolus, and/or palate, which can result in effects on speech, hearing, appearance, and cognition as well as have adverse long-term outcomes in health and social integration.
1,2 The nonsyndromic form of CLP (NSCLP) consists of isolated, nonspecific malformations with no other apparent cognitive or structural abnormalities. 3, 4 NSCLP shows a multifactorial etiology with both genetic and environmental contributions and moderate recurrence rates. 4 Although more than 14 loci may be involved in the development of NSCLP, the precise etiology has not been fully elucidated. 5 Several chromosomal regions, such as 1q, 2p, 4q, 6p, 14q, 17q, and 19q, were suggested to contain genes associated with genetic susceptibility to NSCLP and some syndromic cases. Almost every year, additional loci are identified and added to the susceptibility list, including more recently 8q21.3, 13q31.1, and 15q22 and 15q13. 6, 7 Potentially implicated genes include growth factors (TGFA, TGFB3), transcription factors (MSX1, TBX22, IRF6), genes involved in the metabolism of xenobiotics (CYP1A1, GSTM1, NAT2), genes related to nutritional metabolism (MTHFR, RARA), and genes involved in the immune response (PVLR1).
4,8,9
The association between candidate genes and environmental factors and their influence on the development of CLP have been widely studied by our group. Specially, the muscle segment homeobox gene 1 (MSX1) and genes encoding enzymes involved in folate metabolism, such as methionine synthase (MTR), methylenetetrahydrofolate reductase (MTHFR), and reduced folate carrier 1 (RFC1), have been investigated. 8, 10 Bezerra et al showed a positive association between reduced folic acid levels, alcohol consumption, and the MTHFR 677T and 1298C alleles in NSCLP development. 10 Cardoso et al found no evidence that the MSX1 polymorphisms rs3775261, rs1042484, rs12532, rs6446693, rs4464513, and rs1907998 play a major role in NSCLP. 8 Despite advances in identifying genes associated with the NSCLP development using traditional genetic mapping strategies of candidate genes, genomewide studies, animal models, and epidemiologic and linkage analysis, [8] [9] [10] [11] [12] [13] microarray techniques have become important complementary tools in the search for potential causative CLP genes in genetic studies. These techniques allow investigators to scan the whole genome at once and detect submicroscopic chromosomal imbalances called copy number variants (CNVs).
5,14,15
These genomic imbalances include insertions, duplications, deletions, inversions, recurring mobile elements, and other rearrangements, now usually defined as abnormalities covering 50 or more base pairs. 16 CNV detection is a strategy to identify and confirm candidate disease gene regions, which represents a first-tier diagnostic approach for some diseases.
17,18
In oral clefts studies, microarray-based comparative genomic hybridization (array-CGH) has shown some CNV-region deletions in NSCLP cases at 6q25. For most commonly used arrays, the limit of resolution of ~400 kb throughout the genome provides a reliable ability to identify of pathogenic CNVs, with the median size for presumably benign
CNVs being ~200 kb. 18 However, more recent data with higherdensity arrays suggest that small (1-30 kb) CNVs could contribute to the risk of certain disorders such as neurodevelopmental disorders (NDDs) and autism spectrum disorders (ASDs). 21, 22 Thus, considering the increasing use of microarray analysis as a genetic test for some diseases and the challenges in clinical interpretation regarding size distribution of CNVs in the human genome,
this study aimed to screen the exonic regions of genes identified through overlapping CNVs in patients with NSCLP from the Brazilian northeast. 
| MATERIAL S AND ME THODS

| Study population
| Genomic DNA extraction
The genomic DNA was isolated from whole blood in tubes containing EDTA using the QIAamp DNA Blood Mini Kit (Qiagen, Chatsworth, CA, USA), following the manufacturer's instructions. The obtained DNA was stored at −20°C until analysis.
| CytoScan HD array
To allow the application of DNA samples in a GeneChip HD CytoScan
Array (Affymetrix, Santa Clara, USA), the following processing steps were performed: DNA samples were digested with NSPI restriction enzymes, ligated to adapters and to universal primers that recognize the adapter sequences attached to genomic DNA, genomic DNA was amplified by polymerase chain reaction (PCR), resulting DNA fragments were purified using magnetic sensors, the concentration of purified DNA was quantified with a spectrophotometer, purified samples were fragmented with DNAse I to generate species of 25-125 bp, and fragment size was confirmed by agarose gel electrophoresis. Then, the DNA fragments were end-labeled by the addition of a modified biotinylated base and hybridized to CytoScan Array.
The arrays were sequentially washed and stained with a combination of a streptavidin-coupled dye and a biotinylated anti-streptavidin antibody and, finally, the arrays were scanned. All steps rigorously followed the manufacturer's protocol (http://tools.thermofisher.
com/content/sfs/manuals/cytoscan_assay_user_manual.pdf). The
CytoScan™ HD Array contains greater than 2.4 million markers for copy number and approximately 750 000 genotype-able SNPs, which provide high-resolution copy number, accurate breakpoint estimation, and loss of heterozygosity (LOH) detection.
| Copy number analysis
After array chip scanning, data files were obtained in CEL format, which were then analyzed using the Chromosome Analysis Suite (ChAS) program (Affymetrix, Santa Clara, USA), in order to examine the genomes.
According to recommendations on diagnostic chromosomal microarray testing, microduplications and microdeletions were selected as relevant genomic regions when gains and losses affected a minimum of 50 and 25 markers, respectively, with a lower limit of resolution of ~400 kb. In addition to these parameters, the study analyzed small CNVs (<30 kb).
The main quality indicators for the GeneChip array HD were the median absolute difference paired (MAPD), SD ripple, and SNP-QC.
The parameters were applied to ≤0.25 MAPD, waving SD < 0.12 and ≥15.00 for SNP -QC.
All CNVs generated for each patient, as well as total CNVs, were The use of the list with candidate genes for performing the array analysis was in order to delimit the search field and to study exonic
CNVs that affected only genes associated with phenotype and then to access whether our patients had any changes in these genes. This decision took into account the fact that in a first analysis of all data, a large number of CNVs were generated (2511), but none in particular met traditional criteria to characterize as potential CNV. Then, the small CNVs were analyzed according to the criteria of number of markers and frequency in DGV.
| RE SULTS
All individuals selected for the study had nonsyndromic cleft lip and palate (NSCLP). Table 1 shows the clinical characteristics of the subjects studied. Most individuals were male, with 67% had unilateral cleft against 33% with bilateral cleft. Approximately 54% of the studied individuals have a family history of oral clefts and 20% of patients' mothers confirmed the use of alcohol during pregnancy.
The average age of patients' mothers at conception was 27.8 years.
There were reports of gestational diabetes and obesity during pregnancy of 13% and 27%, respectively. There were no reported cases of parental consanguinity.
Microarray analysis (a-GH) of 15 DNA samples from individuals with NSCLP identified 11 small exonic CNVs affecting at least one exon of the candidate genes (Table 2) , with eight being microdeletions (Loss) and three being microduplications (Gain). Four microdeletions appeared in more than one patient. respectively. These deletions were described in the DGV although rare (esv2761004, nsv830844, nsv5717). A 9.8 kb microdeletion located at 22q11.21 was associated with TBX1. However, it was well described in the DGV. showing a suboptimal number of markers was described in the DGV only once.
| D ISCUSS I ON
The array-CGH technique is an efficient approach for genomewide screening of chromosomal copy number changes and has been shown to be an efficient method to identify submicroscopic gains/ duplications and losses/deletions that can serve as informative markers for clinical phenotypes of various disorders, including orofacial clefts. In our study, a microdeletion in MSX1 was found in two male patients with bilateral NSCLP and family history of oral clefts. The mother of one of these patients informed cigarette smoking and alcohol con- Chr, chromosome; DGV, base genomic data variants; ID, patient identification; Qty, quantity.
related to oxygen availability, and modifications in this gene have been associated with the occurrence of fetal cleft lip due to maternal hypoxia, which can be worsened by maternal hypoxia habits, as smoking and hypertension treatment. 32 A microdeletion at Xp11.22
was described in two brothers with ASD, intellectual disability, and CLP. 33 This microduplication, therefore, seems to be an important factor in the genetic etiology of CLP.
In oral clefts studies, however, little is known about the impor- It is important to note that there was a high frequency of family history among the studied subjects (eight patients), which reflects the strong familial aggregation peculiar to orofacial clefts. Relatives of cleft cases have a high relative risk compared to the population's baseline risk, and there is a sharp decline in risk to relatives of cases with increasingly distant relationships. 35 In this pattern of inheritance, also known as multifactorial threshold model, the probability of sharing identical alleles by descent is constant, be the risk controlled by a gene, some genes or many genes; however, other explanations could potentially result in these same patterns of risk for relatives. 36 In this way, the CNVs found in patients with positive family history of CLP may represent the heritability or the proportion of variation in risk attributable to independent, autosomal genes, whose penetrance at any one of these separate risk genes is impossible to estimate.
In nonsyndromic forms of oral clefts, in which there is no involvement of causal genes strongly associated with risk, it is hypothesized that multiple genetic alterations with modest individual effects on risk may be capable of disrupting normal craniofacial development under specific circumstances given by exposure to environmental risk factors. 36 Therefore, cumulative effect of microdeletions in the copy number of MSX1 could represent a mechanism of deregulation in MSX1 proteins, which are responsible to maintain the growth of the primary palate during mammalian palatogenesis through expression regulation of growth factors such as Bmp4. 37 In the same direction, the effect of microduplication reported in the chromosome region involving the three genes TERT, MIR4457, CLPTM1L may be responsible for an increase in the expression of these genes, promoting an overexpression of apoptotic pathways during the palate morphogenesis.
31
And also, the effect of microduplication of PHF8 may promote a disrupt catalytic of PHF8 activity, which is histone modifying enzyme oxygen dependent, that under conditions of associated hypoxia may be related with chromatin regulated gene expression including of homeobox genes during the development and fusion of facial prominences. 32 Despite evidence that genomic analysis based on arrays has been a robust tool for CNV screening of patients who are suspected to harbor chromosomal aberrations, this technique presents difficulties in classification and interpretation of CNVs, particularly in smaller CNVs. Our study was limited by the unavailability of parental DNA to determine the inheritance patterns of the identified CNVs.
Therefore, researches with more individuals, using secondary confirmatory testing and with comprehensive bioinformatics analysis, are required to better understand exonic CNVs in the size range of 1-30 kb by array-CGH.
In conclusion, our findings represent a preliminary study on the 
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